Kestrel Therapeutics's last reported valuation, Jan 2022. Nothing priced has surfaced since.
- ·Watch Kestrel Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Kestrel Therapeutics funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jul 2025 | Early Stage VC | $5.0M | ▮ | ▮ |
| Feb 2025 | Early Stage VC | $8.0M | ▮ | ▮ |
| Dec 2021 | Early Stage VC | $7.5M | ▮ | ▮ |
Membership and data by Private Market View
Kestrel Therapeutics valuation
Kestrel Therapeutics's last reported valuation was $17.7 million in Jan 2022. No priced round, secondary trade or fund mark has surfaced since.
How much has Kestrel Therapeutics raised?
Kestrel Therapeutics has raised $20.7 million across 3 recorded rounds since 2021. The largest was an $8 million early-stage round in Feb 2025; the most recent was a $5 million early-stage round in Jul 2025.
Kestrel Therapeutics has filed 4 Form Ds with the SEC since 2021, most recently in Aug 2025 ($5 million sold to 6 investors).
How Kestrel Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Kestrel Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about Kestrel Therapeutics
- What is Kestrel Therapeutics worth?
- Kestrel Therapeutics is valued at $17.7M as of Oct 2026. Kestrel Therapeutics's last reported valuation, Jan 2022. Nothing priced has surfaced since.
- How much has Kestrel Therapeutics raised?
- Kestrel Therapeutics has raised $20.7M in total funding across 3 recorded rounds.
- When did Kestrel Therapeutics last raise?
- Kestrel Therapeutics last raised in Jul 2025 (Early Stage VC), raising $5.0M.